Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Medical Cannabis Market by Type (Tetrahydrocannabinol (THC), Cannabidiol (CBD)), By Application (Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028-report

Global Medical Cannabis Market by Type (Tetrahydrocannabinol (THC), Cannabidiol (CBD)), By Application (Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Report ID: 200470 3300 Pharma & Healthcare 377 236 Pages
                                          

Industry Growth Insights published a new data on “Medical Cannabis Market”. The research report is titled “Medical Cannabis Market research by Types (Tetrahydrocannabinol (THC), Cannabidiol (CBD)), By Applications (Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), Others), By Players/Companies BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc, Medical Marijuana Inc”. As per the latest research Medical Cannabis market is expected to expand at a CAGR of xx% in the forecast period.

Scope Of The Report

Report Attributes

Report Details

Report Title

Medical Cannabis Market Research Report

By Type

Tetrahydrocannabinol (THC), Cannabidiol (CBD)

By Application

Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), Others

By Companies

BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc, Medical Marijuana Inc

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2020

Historical Year

2018 to 2019 (Data from 2010 can be provided as per availability)

Forecast Year

2028

Number of Pages

236

Number of Tables & Figures

166

Customization Available

Yes, the report can be customized as per your need.


Global Medical Cannabis Industry Outlook

Global Medical Cannabis Market Report Segments:

The global Medical Cannabis market is segmented on the basis of:

Types

Tetrahydrocannabinol (THC), Cannabidiol (CBD)

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. BOL Pharma
  2. Tilray
  3. Medreleaf Corporation
  4. Aurora Cannabis, Inc
  5. Canopy Growth Corporation
  6. Insys Therapeutics, Inc
  7. Aphria, Inc
  8. MGC Pharmaceuticals Limited
  9. GW Pharmaceuticals, plc
  10. Medical Marijuana Inc

Global Medical Cannabis Market Overview

Highlights of The Medical Cannabis Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

    1. Tetrahydrocannabinol (THC)
    2. Cannabidiol (CBD)
  1. By Application:

    1. Pain
    2. Arthritis
    3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Medical Cannabis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Medical Cannabis Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Medical Cannabis Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Medical Cannabis Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Medical Cannabis Market - Supply Chain
   4.5. Global Medical Cannabis Market Forecast
      4.5.1. Medical Cannabis Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Medical Cannabis Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Medical Cannabis Market Absolute $ Opportunity

5. Global Medical Cannabis Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Medical Cannabis Market Size and Volume Forecast by Type
      5.3.1. Tetrahydrocannabinol (THC)
      5.3.2. Cannabidiol (CBD)
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Medical Cannabis Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Medical Cannabis Market Size and Volume Forecast by Application
      6.3.1. Pain
      6.3.2. Arthritis
      6.3.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
      6.3.4. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Medical Cannabis Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Medical Cannabis Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Medical Cannabis Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Medical Cannabis Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Medical Cannabis Demand Share Forecast, 2019-2026

9. North America Medical Cannabis Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Medical Cannabis Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Medical Cannabis Market Size and Volume Forecast by Application
      9.4.1. Pain
      9.4.2. Arthritis
      9.4.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
      9.4.4. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Medical Cannabis Market Size and Volume Forecast by Type
      9.7.1. Tetrahydrocannabinol (THC)
      9.7.2. Cannabidiol (CBD)
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Medical Cannabis Demand Share Forecast, 2019-2026

10. Latin America Medical Cannabis Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Medical Cannabis Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Medical Cannabis Market Size and Volume Forecast by Application
      10.4.1. Pain
      10.4.2. Arthritis
      10.4.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
      10.4.4. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Medical Cannabis Market Size and Volume Forecast by Type
      10.7.1. Tetrahydrocannabinol (THC)
      10.7.2. Cannabidiol (CBD)
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Medical Cannabis Demand Share Forecast, 2019-2026

11. Europe Medical Cannabis Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Medical Cannabis Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Medical Cannabis Market Size and Volume Forecast by Application
      11.4.1. Pain
      11.4.2. Arthritis
      11.4.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
      11.4.4. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Medical Cannabis Market Size and Volume Forecast by Type
      11.7.1. Tetrahydrocannabinol (THC)
      11.7.2. Cannabidiol (CBD)
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Groth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Medical Cannabis Demand Share, 2019-2026

12. Asia Pacific Medical Cannabis Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Medical Cannabis Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Medical Cannabis Market Size and Volume Forecast by Application
      12.4.1. Pain
      12.4.2. Arthritis
      12.4.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
      12.4.4. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Medical Cannabis Market Size and Volume Forecast by Type
      12.7.1. Tetrahydrocannabinol (THC)
      12.7.2. Cannabidiol (CBD)
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Medical Cannabis Demand Share, 2019-2026

13. Middle East & Africa Medical Cannabis Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Medical Cannabis Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Medical Cannabis Market Size and Volume Forecast by Application
      13.4.1. Pain
      13.4.2. Arthritis
      13.4.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
      13.4.4. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Medical Cannabis Market Size and Volume Forecast by Type
      13.7.1. Tetrahydrocannabinol (THC)
      13.7.2. Cannabidiol (CBD)
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Medical Cannabis Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Medical Cannabis Market: Market Share Analysis
   14.2. Medical Cannabis Distributors and Customers
   14.3. Medical Cannabis Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. BOL Pharma
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Tilray
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Medreleaf Corporation
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Aurora Cannabis, Inc
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Canopy Growth Corporation
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Insys Therapeutics, Inc
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Aphria, Inc
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. MGC Pharmaceuticals Limited
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. GW Pharmaceuticals, plc
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Medical Marijuana Inc
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us